Project Grant R01DE035456
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR), under its Oral Diseases and Disorders Research program (CFDA 93.121), awarded a $363,221 Project Grant to Henry Ford Health + Michigan State University Health Sciences for a two-year research initiative (September 19, 2025 – September 18, 2027). The award supports fundamental and translational research investigating the molecular mechanisms of X chromosome dysregulation in Primary Sjögren's...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of Wisconsin-Madison a Project Grant of $392,918 under the Oral Diseases and Disorders Research program (CFDA 93.121) for the period August 1, 2025 through July 31, 2027. The award funds the development and validation of microphysiological systems (MPSs) designed to recapitulate Sjögren's disease salivary gland pathogenesis. The research addresses a critical gap in therapeutic...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded the Regents of the University of Michigan a $135,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) for the period of August 1, 2025 through July 31, 2027. The grant supports research and development of bioinspired synthetic high-density lipoprotein (SHDL) nanotherapeutics designed to treat apical periodontitis (AP) and promote dental pulp and dentin regeneration....
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of South Alabama a $429,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) effective July 1, 2025, through June 30, 2027. This research project targets phosphodiesterase 4 (PDE4) inhibition as a novel therapeutic approach to address xerostomia and salivary gland dysfunction associated with Sjögren's syndrome. The research will...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded the University of Michigan a Project Grant totaling $219,660 (awarded January 1, 2029) under the Oral Diseases and Disorders Research program (CFDA 93.121) to support research investigating the evolution of pro-tumoral myeloid cells during the initiation of oral cancer. The research focuses on understanding how SOX2-driven genetic alterations in human papillomavirus-negative head and neck squamous cell...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $440,275 through the Oral Diseases and Disorders Research program (CFDA 93.121) to The Research Foundation for the State University of New York, effective February 1, 2026, through January 31, 2028. This Project Grant supports research into the transcriptional regulatory mechanisms governing salivary gland regeneration using a defined genetic mouse model. The research will employ a systems...
- Federal Grant Award Summary The University of Michigan received a $297,137 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective September 11, 2025, with a completion date of March 31, 2027. The research initiative focuses on developing noninvasive diagnostic techniques for detecting and monitoring periodontal inflammation in the approximately 42% of U.S. adults affected by periodontal...
- Federal Grant Award Summary The Oklahoma Medical Research Foundation (OMRF) received a $468,875 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective September 19, 2025, through September 18, 2027. The award supports a two-year research initiative investigating age- and sex-related immune mechanisms involved in salivary gland pathology associated with Sjögren's Disease (SJD), a...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $100,676 Project Grant from the National Institute of Dental and Craniofacial Research under the Oral Diseases and Disorders Research program (CFDA 93.121) effective December 1, 2025, through June 30, 2028. This award supports basic research investigating the developmental role of tissue-resident macrophages (TRMs) during salivary gland morphogenesis. The research addresses a critical gap in understanding salivary...
- Federal Project Grant Award Summary Award Details: The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant of $714,711 to Icahn School of Medicine at Mount Sinai under the Oral Diseases and Disorders Research program (CFDA 93.121). The award period runs from July 1, 2025, through March 31, 2030. Research Objectives and Deliverables: This project addresses salivary gland dysfunction resulting from cancer radiation therapy by developing mechanisms to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded the Regents of the University of Michigan a Project Grant of $527,732 under the Oral Diseases and Disorders Research program (CFDA 93.121) effective February 15, 2026, with completion targeted for January 31, 2031. The grant supports research investigating the role of tissue homeostasis in Sjögren's Disease (SJD), a chronic autoimmune condition characterized by immune cell infiltration of salivary and lacrimal glands. The research aims to elucidate how abnormal cholesterol and lipid metabolic conditions in salivary glands contribute to disease development, with particular focus on understanding defects in exocytosis (salivary protein secretion), acinar cell death, and oxidative stress mechanisms that precede clinical manifestations of SJD. The research deliverables include mechanistic investigations of how cholesterol metabolic abnormalities lead to exocytosis dysregulation and acinar cell death, as well as studies examining the relationship between cholesterol metabolic aberrations and oxidative stress-induced inflammation. The University of Michigan will utilize advanced imaging systems and newly developed transgenic mouse models (GATE16-EGFP reporter mice and INSIG1/2-deficient mice) to track cellular processes and identify novel therapeutic targets and early diagnostic tools for detecting SJD in at-risk populations with lipid metabolism disorders. This research addresses a critical gap in understanding early-stage disease development prior to clinical diagnosis, with potential implications for improved prevention and treatment strategies.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $527.7k | 2/13/26 |